Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

VA/DoD Guidelines Suggest PPIs, H2-Antagonists Work Equally Well For GERD

Executive Summary

H2-antagonists and proton pump inhibitors work equally well for the initial treatment of gastroesophageal reflux disease, a 1draft guideline on clinical practice from the Departments of Defense and Veterans Affairs states

You may also be interested in...



VA/DoD GERD guideline (correction)

Veteran's Affairs/Department of Defense draft guideline states both proton pump inhibitors and H2-antagonists can be used for initial treatment of gastroesophageal reflux disease. "The Pink Sheet" (1April 21, p. 15) incorrectly suggested that the guidelines consider the two drug classes to be equally effective. Both Johnson & Johnson/Eisai's Aciphex (rabeprazole) and TAP's Prevacid (lansoprazole) are included on the Basic Core Formulary...

VA/DoD GERD guideline (correction)

Veteran's Affairs/Department of Defense draft guideline states both proton pump inhibitors and H2-antagonists can be used for initial treatment of gastroesophageal reflux disease. "The Pink Sheet" (1April 21, p. 15) incorrectly suggested that the guidelines consider the two drug classes to be equally effective. Both Johnson & Johnson/Eisai's Aciphex (rabeprazole) and TAP's Prevacid (lansoprazole) are included on the Basic Core Formulary...

DoD/VA Allegra Price Is One-Third Of AWP; Joint Procurement Expands

The Departments of Defense and Veterans Affairs have awarded a joint national procurement contract to Aventis' Allegra (fexofenadine) for approximately one-third the average wholesale price.

UsernamePublicRestriction

Register

OM013164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel